ANALYSIS-Safety concerns block gains for diabetes drugs ... The safety questions have hit diabetes drugs that already face rivals that work similarly. ...

NEW YORK/LONDON (Reuters) - Heightened concern over the safety of new diabetes treatments is... ANALYSIS-Safety concerns block gains for diabetes drugs ...

Comprehensive cancer Information ... Screening not only reason thyroid cancer is rising. ANALYSIS-Safety concerns block gains for diabetes drugs ...

Anti-diabetic drugs treat diabetes mellitus by lowering glucose levels in the blood. ... metformin is the only widely used oral drug that does not cause weight gain. ... Concerns about the safety of rosiglitazone arose when a retrospective ... The meta-analysis was not supported by an interim analysis of the trial ...

Jul 14, 2010 ... GAITHERSBURG, Md (Reuters) - GlaxoSmithKline Plc's diabetes drug ... Analysis: Japan dilemma as economic dependence on China grows ... But some opponents of the drug said the panel voiced enough concerns that the FDA could still ... vote and one analyst predicted further gains in London on Thursday. ...

Apr 2, 2009... unique because it does not cause hypoglycemia or weight gain, ... Those are "the two biggest concerns" for type 2 diabetes patients, she said. An FDA analysis suggested the drug might actually contribute to weight loss. ... Saxagliptin First Diabetes Drug to Pass FDA Cardiovascular Safety Review ...